BIRC5 and neoplasm: Sepantronium selectively suppresses survivin expression to cause activation of caspases and apoptosis induction in hormone refractory prostate cancer cells and has been shown to have broad antitumor activity and induce tumor regressions in various xenograft models [6–9].